InflaRx NV buy Guggenheim
Start price
10.11.25
/
50%
€1.49
Target price
10.11.26
€19.03
Performance (%)
-38.57%
Price
18.12.25
€0.91
Summary
This prediction is currently active. The BUY prediction by Guggenheim for InflaRx NV is performing very badly with a performance of -38.57%. This prediction currently runs until 10.11.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| InflaRx NV | -4.102% | -4.102% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Guggenheim for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ:IFRX) had its price target raised by analysts at Guggenheim from $10.00 to $22.00. They now have a "buy" rating on the stock.
Ratings data for IFRX provided by MarketBeat